Ascendis Pharma’s $150 Million Royalty Funding Agreement with Royalty Pharma

Latham & Watkins and Mazanti-Andersen acted as legal advisors to Ascendis on the transaction, while Goodwin Procter, Kromann Reumert and Fenwick & West acted as legal…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now